Bliss GVS PharmaBLISSGVS 
$1.53-1.97%24h
-1.97%24h
Global rank18597
Market cap$159.02M
Change 7d2.63%
YTD Performance3.13%
SP500 benchmarkUnderperform
P/E0.23
P/S1.79
Revenue$89.00M
Earnings$9.14M
Dividend yield-
Main Sector
Healthcare
Bliss GVS Pharma BLISSGVS Total Debt
BLISSGVS Total Debt in 2022: $5.17M
According to Bliss GVS Pharma latest financial reports the total debt is $5.17M, an increase of 62.49% to 2022. At the end of 2022 company had $3.18M total debt. This figure represents the debts and financial obligations that Bliss GVS Pharma combine short-term debt, long-term debt, and other fixed payment obligations (such as capital leases) of a business that are incurred while under normal operating cycles.
Bliss GVS Pharma BLISSGVS Total Debt History from 2023 to 2022
-
Value:-
BLISSGVS Total Debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023 | $5.17M | 62.49% |
| 2022 | $3.18M | -22.42% |
| 2021 | $4.10M | -14.37% |
| 2020 | $4.79M | 23.59% |
| 2019 | $3.87M | - |
View the Top Total Debt Stocks 
